Trait anxiety but not state anxiety level associates with biomarkers for hypertension in the metabolic syndrome

Psychophysiology

Volumn 53, Issue 6, 2016, Pages 914-920

  Lemche, Alexandra V ^a   Chaban, Oleg S ^b   Lemche, Erwin ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cohort studies; Cross sectional design; Metabolic syndrome; National sample; Pulse pressure; Spielberger State Trait Anxiety Inventory; Structural equation modeling

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ANXIETY; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PSYCHOLOGICAL MODEL;

ADULT; ANXIETY; BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, PSYCHOLOGICAL; OBESITY;

EID: 84959017790     PISSN: 00485772     EISSN: 14698986     Source Type: Journal    
DOI: 10.1111/psyp.12623     Document Type: Article

References (38)

1. Aksoy, S., Durmus, G., Ozcan, S., Toprak, E., & Duman, D. (2014). Is left ventricular diastolic dysfunction independent from presence of hypertension in metabolic syndrome? An echocardiographic study. Journal of Cardiology, 64, 194-198. doi: 10.1016/j.jjcc.2014.01.002
2. Anderson, P. J., Critchley, J. A., Chan, J. C., Cockram, C. S., Lee, Z. S., Thomas, G. N., & Tomlinson, B. (2001). Factor analysis of the metabolic syndrome: Obesity vs insulin resistance as the central abnormality. International Journal of Obesity and Related Metabolic Disorders, 25, 1782-1788. doi: 10.1038/sj.ijo.0801837
3. Atanasova, G. N., & Marinov, M. S. (2013). The pulse pressure amplitude as a marker of myocardial infarction risk. Journal of Clinical and Experimental Cardiology, 4, 251. doi: 10.4172/2155-9880.1000251
4. Bentler, P. M., & Weeks, D. G. (1979). Interrelations among models for the analysis of moment structures. Multivariate Behavioral Research, 14, 169-185. doi: 10.1207/s15327906mbr1402_3
5. Bentler, P. M., & Weeks, D. G. (1980). Linear structural equations with latent variables. Psychometrika, 45, 289-308. doi: 10.1007/BF02293905
6. Brunner, E. J., Hemingway, H., Walker, B. R., Page, M., & Marmot, M. G. (2002). Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation, 106, 2659-2665. doi: 10.1161/01.CIR.0000038364.2631.BD
7. Byrd, J. B., & Brook, R. D. (2014). Anxiety in the "age of hypertension." Current Hypertension Reports, 16, 486. doi: 10.1007/s11906-014-0486-0
8. Carroll, D., Phillips, A. C., Gale, C. R., & Batty, G. D. (2010). Generalized anxiety and major depressive disorders, their comorbidity and hypertension in middle-aged men. Psychosomatic Medicine, 72, 16-19. doi: 10.1097/PSY.0b013e3181c4fca1
9. Chow, C. K., Teo, K. K., Rangarajan, S., Islam, S., & Yusuf, S. (2013). Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA, 310, 959-968. doi: 10.1001/jama.2013.184182
10. Dinel, A. L., Andre, C., Aubert, A., Ferreira, G., Laye, S., & Castanon, N. (2011). Cognitive and emotional alterations are related to hippocampal inflammation in metabolic syndrome. PLoS ONE, 6, e24325. doi: 10.1371/journal.pone.0024325PONE-D-11-08473
11. Domanski, M., Norman, J., Wolz, M., Mitchell, G., & Pfeffer, M. (2001). Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey. Hypertension, 38, 793-797. doi: 10.1161/hy1001.092966
12. Fossum, E., Hoieggen, A., Reims, H. M., Moan, A., Rostrup, M., Eide, I., & Kjeldsen, S. E. (2004). High screening blood pressure is related to sympathetic nervous system and insulin resistance. Blood Pressure, 13, 89-94. PMID: 15182111
13. Grassi, G., Quarti-Trevano, F., Seravalle, G., & Dell'Oro, R. (2007). Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutrition Metabolics and Cardiovascular Disease, 17, 473-481. doi: 10.1016/j.numecd.2007.01.004
14. Grös, D. F., Antony, M. M., Simms, L. J., & McCabe, R. E. (2007). Psychometric properties of the State-Trait Inventory (STAI). Psychological Assessment, 19, 369-381. doi: 10.1037/1040-359.19.4.369
15. Guedes, E. P., Madeira, E., Mafort, T. T., Madeira, M., Moreira, & Farias, M. L. (2013). Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome. Diabetology and Metabolic Syndrome, 5, 82. doi: 10.1186/1758-5996-5-82
16. Hernandez, R., Allen, N. B., Liu, K., Stamler, J., Reid, K. J., & Daviglus, M. L. (2014). Association of depressive symptoms, trait anxiety, and perceived stress with subclinical atherosclerosis. Preventive Medicine, 61, 54-66. doi: 10.1016/j.ypmed.2013.12.032
17. Hjemdahl, P. (2002). Stress and the metabolic syndrome: An interesting but enigmatic association. Circulation, 106, 2634-2636. PMID: 12438283
18. Huang, C. F., Cheng, M. L., Fan, C. M., Hong, C. Y., & Shiao, M. S. (2013). Nicotinuric acid: A potential marker of metabolic syndrome through a metabolomics-based approach. Diabetes Care, 36, 1729-1731. doi: 10.2337/dc12-1067
19. Huggett, R. J., Burns, J., Mackintosh, A. F., & Mary, D. A. (2004). Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension, 44, 847-852. doi: 10.1161/01.HYP.0000147893.08533.d8
20. Kopin, I. J., Lake, R. C., & Ziegler, M. (1978). Plasma levels of norepinephrine. Annals of Internal Medicine, 88, 671-668. PMID: 646261
21. Lambert, E., Dawood, T., Straznicky, N., Sari, C., & Lambert, G. (2010). Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. Journal of Hypertension, 28, 543-555. doi: 10.1097/HJH.0b013e3283350ea4
22. Lemche, A. V., Chaban, O. S., & Lemche, E. (2013). Alexithymia as a risk factor for Type 2 diabetes mellitus in the metabolic syndrome: A cross-sectional study. Psychiatry Research, 215, 438-443. doi: 10.1016/j.psychres.2013.12.004
23. Luppino, F. S., van Reedt Dortland, A. K., Wardenaar, K. J., Bouvy, P. F., Giltay, E. J., Zitman, F. G., & Penninx, B. W. (2011). Symptom dimensions of depression and anxiety and the metabolic syndrome. Psychosomatic Medicine, 73, 257-264. doi: 10.1097/PSY.0b013e31820a59c0
24. Marvar, P. J., Goodman, J., Fuchs, S., Choi, D. C., Banerjee, S., & Ressler, K. J. (2013). Angiotensin Type 1 receptor inhibition enhances the extinction of fear memory. Biological Psychiatry, 1, 864-872. doi: 19.1016/j.biopsych.2013.08.024
25. O'Donovan, A., Hughes, B. M., Slavich, G. M., Lynch, L., Cronin, M. T., O'Farrelly, C., & Malone, K. M. (2010). Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion-biology relationships. Brain Behavior Immunity, 24, 1074-1077. doi: 10.1016/j.bbi.201.03.003
26. Oler, J. A., Fox, A. S., Shelton, S. E., Rogers, J., Dyer, T. D., Davidson, R. J., & Kalin, N. H. (2010). Amygdalar and hippocampal substrates of anxious temperament differ in their heritability. Nature, 466, 864-868. doi: 10.1038/nature09282
27. Räikkönen, K., Matthews, K. A., & Kuller, L. H. (2002). The relationship between psychological risk and metabolic syndrome. Metabolism, 51, 1573-1577.
28. Rogers, J., Raveendran, M., Fawcett, G. L., Fox, A. S., Oler, J. A., & Kalin, N. H. (2013). CRHR1 genotypes, neural circuits and the diathesis for anxiety and depression. Molecular Psychiatry, 18, 700-707. doi: 10.1038/mp.2012.152
29. Roohafza, H., Sadeghi, M., Talaei, M., Pourmoghaddas, Z., & Sarrafzadegan, N. (2012). Psychological status and quality of life in relation to the metabolic syndrome. International Journal of Endocrinology, 2012, 380902. doi: 10.1155/2012/380902
30. Rutledge, T., & Hogan, B. E. (2002). A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosomatic Medicine, 64, 758-766.
31. Szczepanska-Sadowska, E., Cudnoch-Jedrzejewska, A., Ufnal, M., & Zera, T. (2010). Brain and cardiovascular diseases: Common neurogenic background of cardiovascular, metabolic and inflammatory diseases. Journal of Physiology and Pharmacology, 61, 509-521. PMID: 21081794
32. Toschi-Dias, E., Trombetta, I. C., da Silva, V. J., Maki-Nunes, C., Alves, M. J., Angelo, L., & Rondon, M. U. (2013). Symptoms of anxiety and mood disturbance alter cardiac and peripheral autonomic control in patients with metabolic syndrome. European Journal of Applied Physiology, 113, 671-679. doi: 10.1007/s00421-012-2476-8
33. U.S. Burden of Disease Collaborators. (2013). The state of US health, 1990-2010: Burden of diseases, injuries, and risk factors. JAMA, 310, 591-608. doi: 10.1001/jama.2013.13805
34. Vautier, S. (2004). A longitudinal SEM approach to STAI data: Two comprehensive multitrait-multistate models. Journal of Personality Assessment, 83, 167-179. doi: 10.1207/s15327752jpa8302_11
35. Weiber, R., & Mühlhaus, D. (2010). Strukturgleichungsmodellierung [Structural Equation Modeling]. Heidelberg, Germany: Springer-Verlag.
36. World Health Organization. (2009). Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: WHO Press.
37. Yates, K. F., Sweat, V., Yau, P. L., Turchiano, M. M., & Convit, A. (2012). Impact of metabolic syndrome on cognition and brain. Arteriosclerosis, Thrombosis, & Vascular Biology, 32, 2060-2067. doi: 10.1161/ATVBAHA.112.252759
38. Ziegler, M. G., Elayan, H., Milic, M., Sun, P., & Gharaibeh, M. (2012). Epinephrine and the metabolic syndrome. Currrent Hypertension Reports, 14, 1-7. doi: 10.1007/s11906-011-0243-6